Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 41 to 50 of 1509 total matches.
Cytomegalovirus Immune Globulin
The Medical Letter on Drugs and Therapeutics • Oct 21, 1988 (Issue 777)
usually be
resumed when symptoms subside.
The Medical Letter, Vol. 30 (Issue 777) October 21, 1988 p ...
Cytomegalovirus immune globulin (CMVIG) for intravenous administration is now available in the USA on an investigational basis (FE Young and SL Nightingale, JAMA, 260:224, July 8, 1988) for prevention of cytomegalovirus (CMV) infection in CMV-seronegative renal transplant recipients who receive a kidney from a seropositive donor. CMVIG contains IgG antibodies from a pool of healthy donors with high titers of antibodies against CMV. The drug can be obtained from the Massachusetts Department of Public Health Biologic Laboratories (617-522-3700, extension 264) or the American Red Cross...
Dexamethasone Bacterial Meningitis In Children
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989 (Issue 784)
, corticosteroids potentiate ischemic
The Medical Letter, Vol. 31 (Issue 784) January 27, 1989, pp. 6-7
Copyright ...
A recent report in the New England Journal of Medicine suggested that in children with bacterial meningitis, adding the corticosteroid dexamethasone (Decadron; and others) to antibiotic treatment could decrease the incidence of moderate or severe hearing loss.
Flutamide For Prostate Cancer
The Medical Letter on Drugs and Therapeutics • Jul 28, 1989 (Issue 797)
and leuprolide be started
The Medical Letter, Vol. 31 (Issue 797) July 28, 1989, p. 72
Copyright The Medical ...
Flutamide (Eulexin - Schering), an oral antiandrogen, is now available in the USA for treatment of metastatic prostate cancer. Flutamide is recommended by the manufacturer only for use concurrently with an analog of luteinizing hormone-releasing hormone (LHRH) such as leuprolide (Lupron - Medical Letter, 27:71, 1985).
Ovral As A 'Morning-After' Contraceptive
The Medical Letter on Drugs and Therapeutics • Oct 20, 1989 (Issue 803)
The Medical Letter, Vol. 31 (Issue 803) October 20, 1989, pp. 93-94
Copyright The Medical Letter ...
High doses of various hormones have been used for many years to prevent pregnancy after unprotected coitus. Diethylstilbestrol (DES), a synthetic estrogen, was once approved for this purpose by the US Food and Drug Administration (Medical Letter 15:58, 1973), but no drug is now approved for such use. Ovral, an oral contraceptive containing 50 g of the estrogen ethinyl estradiol and 0.5 mg of the progestin norgestrel, has been recommended as a 'morning-after' pill by some physicians (RA Hatcher et al, Contraceptive Technology 1988-1989, 14th ed., New York:Irvington, 1988, page...
Balloon Dilatation Of The Prostate
The Medical Letter on Drugs and Therapeutics • Jun 29, 1990 (Issue 821)
of the
gland if a malignancy is suspected.
The Medical Letter, Vol. 32 (Issue 821) June 29, 1990, p. 64 ...
To avoid the morbidity and occasional mortality of transurethral resection or open prostatectomy, some urologists are now using balloon dilatation of the prostatic urethra to treat benign prostatic hypertrophy.
Gonadorelin For Induction Of Ovulation
The Medical Letter on Drugs and Therapeutics • Jul 27, 1990 (Issue 823)
.
The Medical Letter, Vol. 32 (Issue 823) July 27, 1990, pp. 70-71
Copyright The Medical Letter
UNAUTHORIZED ...
Gonadorelin (goe nad oh rell'; in) acetate (Lutrepulse - Ortho), a synthetic decapeptide identical in amino acid sequence to human gonadotropin-releasing hormone (GnRH), was recently approved by the US Food and Drug Administration for treatment of primary hypothalamic amenorrhea. Gonadorelin hydrochloride (Factrel) was previously available for diagnostic use (Medical Letter, 25:106, 1983). Analogs of GnRH have been used to treat endometriosis and advanced cancer of the prostate (Medical Letter, 27:71, 1985).
Pipecuronium - A New Neuromuscular Blocker
The Medical Letter on Drugs and Therapeutics • Dec 14, 1990 (Issue 833)
.
(continued on next page)
The Medical Letter, Vol. 32 (Issue 833) December 14, 1990, p. 114
Copyright ...
Pipecuronium bromide (Arduan - Organon), a long-acting, non-depolarizing neuromuscular agent chemically related to pancuronium (Pavulon; and others), is now available in the USA for use as a skeletal muscle relaxant during general anesthesia and for endotracheal intubation. It is not recommended for procedures that last less than 90 minutes or for patients requiring prolonged mechanical ventilation in intensive care units.
Safe Needles
The Medical Letter on Drugs and Therapeutics • Apr 05, 1991 (Issue 841)
) phlebotomy
* The availability of some of these products is limited.
The Medical Letter, Vol. 33 (Issue 841 ...
Accidental needlesticks can lead to infection with hepatitis viruses, human immunodeficiency virus, and other blood-borne bacterial, viral, and fungal pathogens (DK Henderson et al, Ann Intern Med, 113:740, 1990). Re-capping used needles is the most frequent cause of needlestick injuries (J Jagger et al, N Engl J Med, 319:284, 1988; MH Becker et al, Am J Infect Control, 18:232, 1990).
Masoprocol for Multiple Actinic Keratoses
The Medical Letter on Drugs and Therapeutics • Oct 15, 1993 (Issue 907)
.
The Medical Letter, Vol. 35 (Issue 907) October 15, 1993, p. 97
Copyright The Medical Letter
UNAUTHORIZED ...
Masoprocol cream 10% (meso-nordihydroguiaretic acid, Actinex - Reed and Carnrick) is now available in the USA for topical treatment of actinic keratoses.
Lodoxamide for Vernal Keratoconjunctivitis
The Medical Letter on Drugs and Therapeutics • Mar 18, 1994 (Issue 918)
, Vol. 36 (Issue 918) March 18, 1994, p. 26
Copyright The Medical Letter
UNAUTHORIZED FORWARDING ...
Lodoxamide, a mast cell stabilizer, has been marketed in a 0.1% ophthalmic solution (Alomide - Alcon) for treatment of vernal keratoconjunctivitis.